journal article
Jul 18, 2014
The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome
Topics
No keywords indexed for this article. Browse by subject →
References
105
[1]
Clements "Myo-inositol content of common foods: development of a high-myo-inositol diet" Am J Clin Nutr (1980) 10.1093/ajcn/33.9.1954
[2]
Hooper "Glycosyl-phosphatidylinositol anchored membrane enzymes" Clin Chim Acta (1997) 10.1016/s0009-8981(97)00161-7
[3]
Di Paolo "Phosphoinositides in cell regulation and membrane dynamics" Nature (2006) 10.1038/nature05185
[4]
Chen "Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis" J Biol Chem (1966) 10.1016/s0021-9258(18)96606-8
[5]
Carman "Phospholipid biosynthesis in yeast" Ann Rev Biochem (1989) 10.1146/annurev.bi.58.070189.003223
[6]
[7]
Huang "Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo" Endocrinology (1993) 10.1210/endo.132.2.8425485
[8]
Larner "D-chiro-inositol-its functional role in insulin action and its deficit in insulin resistance" Int J Exp Diabetes Res (2002) 10.1080/15604280212528
[9]
Larner "Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol" Biochem Biophys Res Commun (1988) 10.1016/s0006-291x(88)80520-5
[10]
Romero "Anti-inositolglycan antibodies selectively block some of the actions of insulin in intact BC3H1 cells" Proc Natl Acad Sci USA (1990) 10.1073/pnas.87.4.1476
[11]
Alvarez "Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment" Biochem J (1991) 10.1042/bj2740369
[12]
Sun "Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls" Biochem Biophys Res Commun (2002) 10.1016/s0006-291x(02)00313-3
[13]
Downes "The cellular functions of myo-inositol" Biochem Soc Trans (1989) 10.1042/bst0170259
[14]
Downes "Myo-inositol metabolites as cellular signals" Eur J Biochem (1990) 10.1111/j.1432-1033.1990.tb19297.x
[15]
Diaz "Micronutrient deficiencies in developing and affluent countries" Eur J Clin Nutr (2003) 10.1038/sj.ejcn.1601820
[16]
Eisenberg "Reproductive tract as site of synthesis and secretion of inositol in the male rat" Nature (1964) 10.1038/202599a0
[17]
Ghafoorunissa "Effect of dietary protein on the biosynthesis of inositol in rat testes" J Reprod Fertil (1975) 10.1530/jrf.0.0420233
[18]
Lewin "Prostatic secretion as the source of myo-inositol in human seminal fluid" Fertil Steril (1973) 10.1016/s0015-0282(16)39910-1
[19]
Lewin "Myo-inositol in the reproductive tract of the female rat" Int J Biochem (1982) 10.1016/0020-711x(82)90154-9
[20]
Chiu "A correlation of the outcome of clinical in vitro fertilization with the inositol content and embryotrophic properties of human serum" J Assist Reprod Genet (1992) 10.1007/bf01204248
[21]
Zacche "Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome" Gynecol Endocrinol (2009) 10.1080/09513590903015544
[22]
Matsuda "Involvement of phospholipase C-related inactive protein in the mouse reproductive system through the regulation of gonadotropin levels" Biol Reprod (2009) 10.1095/biolreprod.109.076760
[23]
Goud "Presence and dynamic redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions" Mol Hum Reprod (1999) 10.1093/molehr/5.5.441
[24]
Lowther "Maturation, fertilization, and the structure and function of the endoplasmic reticulum in cryopreserved mouse oocytes" Biol Reprod (2009) 10.1095/biolreprod.108.072538
[25]
Chiu "Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes" Hum Reprod (2003) 10.1093/humrep/deg113
[26]
Kane "Uptake and incorporation of inositol by preimplantation mouse embryos" J Reprod Fertil (1992) 10.1530/jrf.0.0960617
[27]
Fahy "Incorporation of [3H]inositol into phosphoinositides and inositol phosphates by rabbit blastocysts" Mol Reprod Dev (1993) 10.1002/mrd.1080340407
[28]
Holm "High bovine blastocyst development in a static in vitro production system using SOFaa medium supplemented with sodium citrate and myo-inositol with or without serum-proteins" Theriogenology (1999) 10.1016/s0093-691x(99)00162-4
[29]
Holub "Metabolism and function of myo-inositol and inositol phospholipids" Annu Rev Nutr (1986) 10.1146/annurev.nu.06.070186.003023
[30]
Colazingari "Improvement of mouse embryo quality by myo-inositol supplementation of IVF media" J Assist Reprod Genet (2014) 10.1007/s10815-014-0188-1
[31]
Stachecki "Transient release of calcium from inositol 1,4,5-trisphosphate-specific stores regulates mouse preimplantation development" Development (1996) 10.1242/dev.122.8.2485
[32]
Huang "Increase in cytoskeletal actin induced by inositol 1,4-bisphosphate in saponin-permeated pig platelets" Cell Biol Int (1994) 10.1006/cbir.1994.1112
[33]
Ducibella "Regulation of the polyspermy block in the mouse egg: maturation-dependent differences in cortical granule exocytosis and zona pellucida modifications induced by inositol 1,4,5-trisphosphate and an activator of protein kinase C" Biol Reprod (1993) 10.1095/biolreprod48.6.1251
[34]
Orihuela "Inositol triphosphate participates in an oestradiol nongenomic signalling pathway involved in accelerated oviductal transport in cycling rats" J Endocrinol (2006) 10.1677/joe.1.06448
[35]
Carlomagno G Roseff S Harter S Murphy Cohen S Unfer V A novel approach for treating infertile patients with diminished ovarian reserve (DOR) 2011
[36]
Visser "Anti-Mullerian hormone and folliculogenesis" Mol Cell Endocrinol (2005) 10.1016/j.mce.2004.09.008
[37]
Visser "Anti-Mullerian hormone: a new marker for ovarian function" Reproduction (2006) 10.1530/rep.1.00529
[38]
Quirk "Myo-Inositol homeostasis in the human fetus" Obstet Gynecol (1983)
[39]
Hallman "Inositol supplementation in respiratory distress syndrome: relationship between serum concentration, renal excretion, and lung effluent phospholipids" J Pediatr (1987) 10.1016/s0022-3476(87)80561-9
[40]
Greene "Inositol prevents folate-resistant neural tube defects in the mouse" Nat Med (1997) 10.1038/nm0197-60
[41]
Hendricks "Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans" Epidemiology (2001) 10.1097/00001648-200111000-00009
[42]
Reece "Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats" Am J Obstet Gynecol (1997) 10.1016/s0002-9378(97)70543-x
[43]
Goldman "Biochemical basis of the diabetic embryopathy" Isr J Med Sci (1991)
[44]
Cavalli "Inositol and folate resistant neural tube defects" J Med Genet (2002) 10.1136/jmg.39.2.e5
[45]
Beemster "Involvement of inositol in reproduction" Nutr Rev (2002) 10.1301/00296640260042748
[46]
Dunaif "Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome" Diabetes (1989) 10.2337/diab.38.9.1165
[47]
Ehrmann "Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome" Diabetes Care (1999) 10.2337/diacare.22.1.141
[48]
Legro "A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome" J Clin Endocrinol Metab (1998)
[49]
Legro "Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors" Fertil Steril (1999) 10.1016/s0015-0282(99)00401-x
[50]
Franks "Polycystic ovary syndrome" N Engl J Med (1995) 10.1056/nejm199509283331307
Showing 50 of 105 references
Cited By
78
Alternative routes for production of the drug candidate d-chiro-inositol with Corynebacterium glutamicum using endogenous or promiscuous plant enzymes
Metabolic Engineering
Paul Ramp, Christina Mack · 2023
Metrics
78
Citations
105
References
Details
- Published
- Jul 18, 2014
- Vol/Issue
- 54(10)
- Pages
- 1079-1092
- License
- View
Authors
Cite This Article
Simona Dinicola, Tony T. Y. Chiu, Vittorio Unfer, et al. (2014). The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. The Journal of Clinical Pharmacology, 54(10), 1079-1092. https://doi.org/10.1002/jcph.362
Related
You May Also Like
The Anticholinergic Drug Scale as a Measure of Drug‐Related Anticholinergic Burden: Associations With Serum Anticholinergic Activity
Ryan M. Carnahan, Brian C. Lund · 2006
563 citations
Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual‐Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)
Jessie Gu, Adele Noe · 2010
431 citations
Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study
G. Ghirlanda, A. Oradei · 1993
232 citations
Interaction of Warfarin With Drugs, Natural Substances, and Foods
David J. Greenblatt, Lisa L. von Moltke · 2005
141 citations